Marker Therapeutics MRKR
NASDAQ MRKR
$1.06 +0.01 (+0.95%)
As of: Oct 2, 2026 · 11:11 AM EDT

Marker Therapeutics (MRKR) Depreciation & Amortization (CF) (2019 - 2023)

Updated

Marker Therapeutics (MRKR) posted Depreciation & Amortization (CF) of $818,216 for Q1 2023, up 42.0% from $576,331 a year earlier and up 0.6% from the prior quarter.

Analysis

Marker Therapeutics (MRKR) Depreciation & Amortization (CF) (2019 - 2023) Analysis & Trends

For the trailing twelve months through Mar 31, 2023, Depreciation & Amortization (CF) at Marker Therapeutics was $3.03 million, up 36.4% year-over-year; for FY2022, it came in at $2.79 million, up 29.8% from FY2021.

  • Annual Depreciation & Amortization (CF) has increased for three consecutive years, with a three-year compound annual growth rate of 198.3% (FY2019 to FY2022).
  • In prior years, Marker Therapeutics' Depreciation & Amortization (CF) was $2.15 million in FY2021 (+342.5%), $485,641 in FY2020 (+362.0%) and $105,123 in FY2019.
  • Quarterly Depreciation & Amortization (CF) has run from a low of $10,514 in Q1 2019 to a high of $819,883 in Q3 2022 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last eight quarters, with growth averaging 136.2% over the last eight quarters.
  • The year-over-year growth in Depreciation & Amortization (CF) has ranged between 9.3% (Q2 2022) and 522.3% (Q4 2020) over the last five years.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $813,110 (Q4 2022), $819,883 (Q3 2022) and $579,782 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Marker Therapeutics 17.87 Mn -42.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 818,216.00
Dec 31, 2022 813,110.00
Sep 30, 2022 819,883.00
Jun 30, 2022 579,782.00
Mar 31, 2022 576,331.00
Dec 31, 2021 564,488.00
Sep 30, 2021 551,524.00
Jun 30, 2021 530,228.00
Mar 31, 2021 502,743.00
Dec 31, 2020 212,916.00
Sep 30, 2020 148,098.00
Jun 30, 2020 89,362.00
Mar 31, 2020 35,265.00
Dec 31, 2019 34,215.00
Sep 30, 2019 31,097.00
Jun 30, 2019 29,297.00
Mar 31, 2019 10,514.00
API Access

Marker Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MRKR&period=max&api_key=YOUR_API_KEY